1.
Panminerva Med
; 32(2): 85-7, 1990.
Artigo
em Inglês
| MEDLINE
| ID: mdl-2250979
RESUMO
Nimodipine therapy (30 mg x 3/die) was commenced in twenty-eight patients affected by chronic ischemic cerebral vasculopathies and continued for the 90 days in order to evaluate drug efficacy. Clinical controls were carried out 4, 8 and 12 weeks after the start of therapy using Doppler, ultrasound and neurological tests (the letter based on the SCAG neurological scale). Hemodynamic and hematochemical parameters were also monitored and controlled.
Assuntos
Transtornos Cerebrovasculares/tratamento farmacológico , Nimodipina/uso terapêutico , Adulto , Idoso , Transtornos Cerebrovasculares/fisiopatologia , Doença Crônica , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Fatores de Risco
2.
Minerva Med
; 82(1-2): 29-31, 1991.
Artigo
em Italiano
| MEDLINE
| ID: mdl-2000170
RESUMO
Personal experience of pacemakers in patients suffering from (symptomatic and asymptomatic) 2nd degree AVB and 3rd degree AVB is reported.